ArticleClinical ophthalmology (Auckland, N.Z.)2025
Surgical Management of Primary Congenital Glaucoma: Results of a Nationwide Descriptive Study in France (CONGLAU).
Article in Clinical ophthalmology (Auckland, N.Z.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Nonpenetrating Deep Sclerectomy versus Conventional Surgery in Primary Congenital Glaucoma: a Systematic Review and Meta-analysis.Ophthalmology and therapy · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Childhood glaucoma is rare but severe, with no recognized standard surgical procedure. We conducted a retrospective, observational, multicenter study describing surgical practices for primary congenital glaucoma (PCG) in France. Patients and methods: This study was conducted between 2013 and 2018 using data from PCG patients aged <4 years at 16 reference centers in France. Intraocular pressure (IOP) (baseline [pre-surgery], 1 month, 1 year), initial surgical procedure, antimitotic (mitomycin C [MMC]) use, secondary intervention(s), and surgical success (complete, relative, or failure) were recorded. Results: Overall, 116 eyes (83 patients) were included. The most common surgeries were trabeculotomy (31.0%) and trabeculotomy combined with trabeculectomy (20.7%). A further 11 other types of surgery were performed for <10% of eyes. Median IOP was reduced in each surgical group at 1 month (the largest median reduction being for combined trabeculotomy/non-perforating deep sclerectomy [-60%]) and at 1-year (the largest median reduction being for trabeculectomy [-55%]). Anti-glaucomatous treatment was administered in 30.4% of cases, most commonly for trabeculectomy (66.7%). Complete and relative surgical success were observed for 21.5% and 33.6% of surgical procedures overall, with complete success most common for trabeculotomy (47.1%). When MMC was used (51.8% of surgical procedures overall, excluding trabeculotomy), surgery was less successful (complete success 3.6% Conclusion: There was a trend towards better effectiveness of angle-based surgery (eg, trabeculotomy). The findings suggest that MMC may not be essential in first-line PCG surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.